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Prokaryotic ATP-binding cassette (ABC) importers require a substrate-binding protein (SBP) for 
the capture and delivery of the cognate substrate to the transmembrane domain (TMD) of the 
transporter. Various biochemical compounds have been identified that bind to the SBP but are not 
transported. The mechanistic basis for the ‘non-cognate’ substrates not being transported differs. 
Some non-cognate substrates fail to trigger the appropriate conformational change in the SBP, 
resulting in loss of affinity for the TMD or the inability to allosterically activate transport. In 
another mechanism, the SBP cannot release the bound non-cognate substrate. Here, we used rate 
equations to derive the steady-state transport rate of cognate substrates of an ABC importer and 
investigated how non-cognate substrates influence this rate. We found that under limiting non-
cognate substrate concentrations, the transport rate remains unaltered for each of the mechanisms. 
In contrast, at saturating substrate and SBP concentrations, the effect of the non-cognate substrate 
depends heavily on the respective mechanism. For instance, the transport rate becomes zero when 
the non-cognate substrate cannot be released by the SBP. Yet it remains unaffected when 
substrate release is possible but the SBP cannot dock onto the TMDs. Our work shows how the 
different mechanisms of substrate inhibition impact the transport kinetics, which is relevant for 
understanding and manipulating solute fluxes and hence the propagation of cells in nutritionally 
complex milieus. 
 













ATP-binding cassette (ABC) transporters form a large family of membrane transport proteins1-3 
with a common domain architecture. The translocator unit is composed of two transmembrane 
domains (TMDs), which form the translocation pathway for the substrate, and two cytoplasmic 
nucleotide-binding domains (NBDs), which bind and hydrolyse ATP. ABC transporters use the 
energy of ATP hydrolysis to transport various compounds, such as sugars, amino acids, vitamins, 
compatible solutes, metal ions, antibiotics, lipids, polypeptides, and many others1. Some ABC 
transporters are specific for a single compound4, whereas others have broad substrate specificity 
and are able to transport multiple compounds5,6. The proposed transport mechanism of ABC 
transporters is based on the alternating access model7,8, in which the translocator switches 
between inward- and outward-facing conformations to expose a substrate binding cavity on 
alternate sides of the membrane. 
ABC importers are typical of prokaryotic organisms but recently a number of proteins with the 
‘exporter fold’ have been discovered that mediate cellular uptake, both in prokaryotic and 
eukaryotic cells9,10. Both Type I and II ABC importers require a soluble extracellular or 
periplasmic substrate-binding protein (SBP) for their function11,12. In Gram-positive bacteria and 
archaea, the SBPs are attached to the membrane via a lipid- or protein anchor, or are directly 
fused to the TMDs13,14. In Gram-negative bacteria, most SBPs are present as soluble protein in the 
periplasmic space, but some are lipid-anchored15 or tethered to the TMD of the ABC transporter16, 
which is analogous to the surface association of SBPs in Gram-positive bacteria and archaea. The 
SBP binds the transported substrate, i.e., the cognate substrate, for delivery to the translocator 
unit. SBPs share a domain architecture, consisting of two rigid subdomains connected by a 
flexible hinge region11. Binding of a cognate substrate brings the two subdomains together, 
thereby switching the SBP from an open to a closed conformation17-19. Different closed 
conformations can be formed with different cognate substrates20. These closed conformations 
productively interact with the translocator and activate transport and the ATPase activity21-23.  
Various biological compounds have been identified that bind to SBPs but are not transported 
by ABC importers6,23-29. These non-transported molecules are termed herein non-cognate 
substrates, whereas the molecules taken up are named cognate substrates. To date, non-cognate 
substrates have been identified for various ABC importers, including the maltose importer 
MalFGK2 of Escherichia coli
29, the amino acid importer GlnPQ of Lactococcus lactis20, the Mn2+ 
importer PsaBCA of Streptococcus pneumoniae30, the osmoregulatory transporter OpuA of L. 
lactis24, the peptide importer OppABCDF of L. lactis27, the alginate importer AlgM1M2SS of 












cognate substrates can act as inhibitors of cognate substrate transport and thereby severely affect 
the transport rate in vitro and in vivo20,25,28,29. Note that this type of inhibition is distinct from 
trans-inhibition that exist in some ABC importers31,32. In the trans-inhibition mechanism the 
importer contains additional regulatory domains fused to the NBDs. Here, the activity of the 
transporter is regulated by the transported cognate substrate31,32. For instance, the transport of 
cognate L- and D-methionine by the E. coli MetINQ system is regulated by the internal pool of L-
methionine33. 
Many non-cognate substrates induce a conformational change in the SBP that is distinct from 
that of cognate substrates20,34,35. For instance, the SBP MalE can bind maltotetraitol, β-
cyclodextrin and maltotetraose with high affinity, but only maltotriose is transported25. 
Maltotriose induces closing of MalE, whereas maltotetraitol and β-cyclodextrin trigger the 
formation of different conformational states20,34,35. In other SBPs, the non-cognate substrate does 
not induce a conformational change within the SBP20. These observations provided possible 
explanations why the non-cognate substrate cannot be transported: the SBP-non-cognate substrate 
complex fails to interact with the translocator (model A; Figure 1) or it docks onto the translocator 
but fails to activate ATPase activity and transport (model B; Figure 1).  
In the Mn2+ importer PsaBCA of S. pneumoniae, a third mechanism of substrate inhibition is 
prevalent20,30. Here, both cognate Mn2+ and non-cognate Zn2+ induce highly similar closing of the 
SBP PsaA. However, the PsaA-Zn2+ complex is so stable that PsaA cannot open and release the 
metal ion to the PsaBC unit (model C; Figure 1)20,26,30,36. Reversible and irreversible substrate 
binding has also been shown for YtgABC37. Thus, the rate of transport is not only influenced by 
the conformational state of the substrate-bound SBP but also by the substrate release kinetics.  
In this paper, we used rate equations to analyse how non-cognate substrates influence the 
kinetics of transport. We considered three inhibition mechanisms of the non-cognate substrate that 
we here describe as model A, B and C. The most drastic differences between the models are found 
at saturating cognate and non-cognate substrate and saturating SBP concentrations. Then, the 
transport rate is not influenced by the non-cognate substrate in model A, the transport rate is 
partially reduced in model B, and transport is completely inhibited in model C. These findings 
show that the influence of the non-cognate substrate on the rate of cognate substrate transport 















We modelled the transport cycle of an ABC importer by a minimal mathematical model based on 
available biochemical and structural data1-3. We focus on Type I ABC importers, as they are 
structurally and mechanistically different from other ABC importers38. We constructed four 
reaction schemes that model how a cognate substrate is transported, and how a non-cognate 
substrate interacts with the importer but is not transported (Figure 1). These models are termed 
model 0, A, B and C. The transport of cognate substrate is modelled in the absence of non-cognate 
substrate (model 0) and in its presence (model A, B and C). The difference between models A, B 
and C relates solely to how the non-cognate substrate is bound by the SBP and how the non-
cognate substrate-SBP complex interacts with the translocator. The models consist of different 
states Xi, which are connected via rate constants kj. 
First, we describe the common steps of model 0, A, B and C, that are, the steps that involve 
the transport of cognate substrate (Figure 1). The first step is the reversible binding of cognate 
substrate X6 to the open conformation of the SBP X1 with an association and dissociation rate 
constant k1 and k2, respectively. Binding of the cognate substrate induces immediate closing of the 
SBP19. The substrate-free (open) and substrate-bound (closed) states of the SBP are denoted by X1 
and X2, respectively. In our models, we ignore any other SBP states, such as a substrate-free 
closed or a substrate-bound open conformation, as these states represent only a very small fraction 
of the total SBP population and/or short-lived19,20,39-42. Next, the substrate-bound SBP docks onto 
the inward-facing conformation of the translocator with an association rate constant k3. The 
formed complex is denoted X3 and the free translocator X5. Once docked on the translocator, the 
SBP can either undock (with a rate constant k4) or transfer the cognate substrate to the TMDs (rate 
constant k5). In this latter step, the SBP has to open and release the substrate into the TMD cavity 
of the outward-facing conformation43. The formed complex is denoted X4. In the final step, ATP 
hydrolysis triggers formation of the inward-facing conformation and release of the cognate 
substrate into the cytoplasm. We assume that all these processes occur with rate constant k6 in an 
irreversible process. By making the step with rate constant k5 and k6 irreversible, the transporter 
can only function in the import direction and it can only hydrolyse and not synthesise ATP. In our 
models we do not consider the proposed non-canonical mechanism of transport, in which SBP 
docking would precede substrate binding44,45. 
Next, we describe the additional steps of model A, B and C describing how a non-cognate 
substrate binds to the SBP and how the non-cognate substrate-SBP complex interacts with the 
importer (Figure 1). In model A (Figure 1), the non-cognate substrate X7 binds to the open 
conformation of the SBP X1 with an association and dissociation rate constant k7 and k8, 
respectively. The SBP with a non-cognate substrate bound is denoted by X8. In model A, it is 












SBP20,34,35 so that the SBP has no affinity for the translocator. Thus, the key characteristic of 
model A is that transport fails because the non-cognate substrate-SBP complex cannot dock onto 
the translocator. Model A is exemplified by the action of non-cognate substrates arginine and 
lysine of amino-acid importer GlnPQ, as these compounds leave the structure of SBD1 in the 
open conformation20. 
In model B (Figure 1), the non-cognate substrate is bound reversibly by the SBP with an 
association and dissociation rate constant k7 and k8, respectively. Contrary to model A, the non-
cognate substrate-bound SBP can dock on to the translocator with an association and dissociation 
rate constant k9 and k10, respectively. The transport in model B, however, fails because the non-
cognate substrate-SBP complex does not activate the translocator. We have previously shown that 
many non-cognate substrates induce a conformational change in the SBP that is distinct from 
those induced by cognate substrates20,34,35. Thus, transport fails because the required allosteric 
interactions between the SBP and TMD are not made. Potential examples of model B are the 
substrates histidine of GlnPQ and maltotetraitol and β-cyclodextrin of the E. coli maltose 
importer, which induce an SBP conformation that is different from that with cognate 
substrates20,34,35.  
Transport of non-cognate substrate fails in model C (Figure 1) because the non-cognate 
substrate binds irreversibly to the SBP (at least on any biologically relevant timescale). 
Irreversible substrate binding has been shown for the importers PsaBCA20,30 and YtgABC37. In 
model C, the non-cognate substrate binds to the SBP with a rate constant k7 and locks the SBP in 
the closed state. The SBP cannot open, so the substrate dissociation rate constant is equal to zero. 
After the complex between the non-cognate substrate and the SBP has been formed, it can dock 
onto the translocator with an association rate constant k9. Next, the SBP can only undock again 
(with a rate constant k10) but it cannot open and transfer the substrate to the translocator.  
 
Comparing models 
By using the law of mass action for each step of the reaction mechanism, we can formulate the 
equations that describe the time evolution of the concentrations of state Xj (see Supplementary 
Information for details). We calculated the steady-state transport rate of a single translocator of 



















𝑖  is the steady-state concentration of state X4 of model 𝑖 and 𝑟 is the total translocator 






where 𝑖 ∈ {𝐴, 𝐵, 𝐶}. The 𝑗𝑖 value is indicative for the amount of inhibition by the non-cognate 
substrate: the transport rate of cognate substrate is not influenced by the presence of non-cognate 
substrate when 𝑗𝑖 = 1, transport is completely inhibited when 𝑗𝑖 = 0, and transport occurs with a 
reduced rate when 0 < 𝑗𝑖 < 1. Formally, 𝑣𝑖 and 𝑗𝑖 are functions of the rate constants, the total 
non-cognate substrate concentration 𝐿, the total cognate substrate concentration 𝑙, the total SBP 
concentration 𝑏, and the total translocator concentration 𝑟. However, for notational convenience 
we will omit this explicit dependence throughout this paper. 
To compare the steady-state transport rates for the different models, we numerically solved the 
steady-state concentrations for a particular set of parameter values. We chose parameters that 
reflect known cases and typical assumptions and conditions of Type I importers. First, 𝑏 was set 
to 20 µM and 𝑟 to 1 µM, so that the SBP to translocator ratio is 20:146-49. The rate constants k1 and 
k7 were set to 10 s
-1 µM-1 and k2 and k8 to 10 s
-1, thereby fixing the cognate and non-cognate 
dissociation constant KD to 1 µM
21,29. The rate constants k3 and k9 were set to 1 s
-1 µM-1 and k4 to 
10 s-1 and k10 to 20 s
-1, thereby fixing the KD between the SBP and the translocator to 10 µM when 
the SBP has a cognate substrate bound and to 20 µM when a non-cognate substrate is bound48,50-
52. We chose k5 and k2 to be equal, because both steps involve the opening of the SBP and release 
of substrate. Finally, k6 was set to 4 s
-1, so that the maximal turnover rate is k5k6 /(k5+k6)  3 s
-1 14. 
Unless stated otherwise, we used these rate constants throughout this paper.  
Figure 2 shows 𝑣𝑖 for a total cognate substrate concentration between 0 and 60 µM and in the 
presence and absence of 15 µM non-cognate substrate. We observe that 𝑣0 increases with cognate 
substrate and approaches a maximum at high concentrations. This behaviour is also commonly 
observed experimentally21. In the presence of 15 µM of non-cognate substrate, we see that the 
amount of inhibition is model dependent. Transport is most severely inhibited when the non-
cognate substrate binds irreversibly to the SBP (model C). Inhibition is the least when the non-
cognate substrate binds reversibly and the non-cognate substrate-bound SBP cannot dock onto the 
translocator (model A). This conclusion seems to hold for every cognate substrate concentration, 
however, at low concentrations the difference between the models becomes smaller or even 
disappears when the concentration approaches zero (see Section ‘Low substrate concentration’). 
To put it more formally, Figure 2 shows that 𝑗𝐴 ≥ 𝑗𝐵 ≥ 𝑗𝐶  irrespective of the precise cognate 












To analyse if this conclusion depends on the particular choice of model parameters, such as 
the total SBP concentration or the rate constants, we compared a large set of 𝑗𝐴, 𝑗𝐵  and 𝑗𝐶  values, 
which were calculated with random model parameters (details in Supplementary Information). 
The model parameters (i.e., the rate constants and 𝐿, 𝑙, 𝑏 and 𝑟) were randomly drawn from a 
broad distribution. In total, 8·104 random model parameter combinations were used to calculate 
𝑗𝐴, 𝑗𝐵  and 𝑗𝐶 . In Figure 3, the histograms for the resulting (𝑗𝐴, 𝑗𝐵), (𝑗𝐵 , 𝑗𝐶) and (𝑗𝐴, 𝑗𝐶) pairs are 
shown. We observe that the amount of inhibition in model A is always less than or equal to model 
B and C (𝑗𝐴 ≥ 𝑗𝐵  and 𝑗𝐴 ≥ 𝑗𝐶 ), and that the inhibition in model B is always less than or equal to 
model C (𝑗𝐵 ≥ 𝑗𝐶 ) (Figure 3). Therefore, we conclude that: 𝑗𝐴 ≥ 𝑗𝐵 ≥ 𝑗𝐶  irrespective of the rate 
constants or protein and substrate concentrations. Secondly, we see with certain model parameter 
combinations that transport is not influenced by the presence of non-cognate substrate (𝑗𝑖 = 1). 
Thirdly, with certain model parameter combinations, drastic differences are observed between 
model A, B and C, e.g., 𝑗𝐴 = 1 and 𝑗𝐵 = 0. These cases will be analysed in more detail in the next 
sections. 
For simplicity, we treated many of the downstream steps of the transport cycle as a single step. 
To rule out that the conclusions depend on this oversimplification, we also considered several 
alternative model topologies, in which an additional step is included after substrate transfer to the 
TMDs (Figure S1a-c), the cognate substrate is translocated across the membrane before the SBP 
undocks (Figure S2a-c) or the SBP undocks before the cognate substrate is translocated (Figure 
S3a-c). Random parameter combinations were simulated and we find that the conclusions for the 
models of Figure 1 are also valid for the alternative model topologies (compare Figure 3 with 
Figure S1d, Figure S2d and Figure S3d). This suggests that our conclusions are not strictly model 
dependent. 
 
Low substrate concentration  
When both cognate and non-cognate substrate concentrations are low compared to the SBP and 
translocator concentration, then we can make the approximation that 𝑏 = 𝑋1
𝑖  and 𝑟 = 𝑋5
𝑖 , where 
𝑋𝑗
𝑖 is the steady-state concentration of state Xj of model 𝑖. With this approximation, the models 
can be solved analytically under steady-state conditions (see Supplementary Information). We 




𝑘246 + 𝑘256 + (𝑘146 + 𝑘156)𝑏 + (𝑘135 + 𝑘136)𝑏𝑟 + 𝑘356𝑟
 (3) 
where 𝑖 ∈ {0, 𝐴, 𝐵, 𝐶} and 𝑘𝑥𝑦𝑧 = 𝑘𝑥𝑘𝑦𝑘𝑧. The 𝑣𝑖’s calculated with Eq. 3 are in good agreement 












𝑣𝐴, 𝑣𝐵 and 𝑣𝐶 are equal at low substrate concentrations, implies that 𝑗𝐴, 𝑗𝐵  and 𝑗𝐶  approaches the 
limit 
 𝑗𝐴 = 𝑗𝐵 = 𝑗𝐶 = 1 (4) 
Thus, when the non-cognate substrate concentration is much higher than the cognate substrate 
concentration, but both are low compared to the protein concentrations, transport is not inhibited 
in model A, B and C. Since the typical translocator and SBP concentrations are in the M-mM 
range46-49, the result of Eq. 4 should apply when the cognate and non-cognate substrates are 
present in sub-M concentrations or lower, which is not uncommon for bacteria in e.g. marine 
environments and may evoke a selective advantage on expressing SBP at high levels.  
 
High substrate concentration 
Next, we analysed the situation that the substrates are available to the SBP at saturating 
concentrations (i.e. 𝑙 ≫ 𝑏 and 𝐿 ≫ 𝑏) and the SBP is present in large excess of the translocator 
concentration (i.e. 𝑏 ≫ 𝑟). The first condition is important for ABC importers in bacteria that are 
(transiently) exposed to high nutrient concentrations such as gut microbiota and 
enterobacteriaceae46-49,53. In a subset of ABC transporters (abundantly present in firmicutes), 
multiple SBPs are directly linked to the importer, giving rise to more than one SBP per transporter 
complex13. Under the here analysed conditions, all free SBPs have a cognate or non-cognate 
substrate bound and the majority of translocators have an SBP bound. Simple analytical results can 
be obtained in this case (see Supplementary Information). To ensure that all limits of this section 
exist we only look at 0 < 𝐿 𝑙⁄ < ∞, where 𝐿 𝑙⁄  is the ratio of non-cognate substrate over cognate 
substrate concentration.  




𝑘46 + 𝑘56 + (𝑘35 + 𝑘36)𝑏
 (5) 


























 𝑣𝐶 = 0 (8) 
By using Eq. 6, 7 and 8, we calculated the transport rate at high substrate concentrations and with 
a total SBP and translocator concentration of 25 and 0.5 µM, respectively. We see that the rates 
calculated with Eq. 6, 7 and 8 are in good agreement with the numerical solution, in which no 
approximations are made (Figure 5a).  
To gain more insight in the amount of inhibition for each non-cognate interaction mechanism, 






(𝑘1468 + 𝑘1568)𝑙 + (𝑘1358 + 𝑘1368)𝑏𝑙







(𝑘1468 + 𝑘1568)𝑙 + (𝑘1358 + 𝑘1368)𝑏𝑙










= 0 (11) 
From Eq. 9, 10 and 11 we conclude that transport still occurs when the non-cognate substrate 
binds reversibly to the SBP (model A and B). In contrast, irreversible binding (model C) 
completely inhibits transport under these conditions (see also Figure 5a). The interpretation of this 
result is simple. When the non-cognate substrate concentration is higher than the SBP 
concentration (𝐿 > 𝑏) and the binding is irreversible, all the SBPs have a non-cognate substrate 
bound, so that no SBPs are available for transport. In model A and B, only a fraction of the SBPs 
have a non-cognate substrate bound, so leaving the others free to participate in transport.  
From Eq. 9 and Eq. 10 we see that when the cognate substrate concentration becomes much 
larger than the non-cognate substrate concentration, we have that 𝑗𝐴 → 1 and 𝑗𝐵 → 1. However, 
this is not true for 𝑗𝐶 , unless the non-cognate substrate concentration is negligible compared to the 
SBP and translocator concentration (see Section ‘Low substrate concentration’). These 
observations are consistent with the expected non-competitive inhibition mode for model C and 
competitive inhibition mode for model A and B. 
Next, we analyse how 𝑗𝐴 and 𝑗𝐵  (as given by Eq. 9 and 10, respectively) depend on the total 
SBP concentration; a variable that might be adjusted by the cell49. In Figure 5b, 𝑗𝐴 is shown for 












SBP concentration (Figure 5b). When the translocator becomes saturated with SBP (Figure 5c), 
then the following limit is obtained 
 𝑗𝐴 = 1 (12) 
This means that transport becomes insensitive to non-cognate substrate. This conclusion is valid 
irrespective of the rate constants and the substrate, SBP and translocator concentration, as long as 
the substrates and SBPs are both present at saturating levels.  
By using Eq. 10 we calculated 𝑗𝐵  for different SBP concentrations (Figure 5d). We see that 
contrary to model A, an intermediate value of 𝑗𝐵  is obtained when the translocators are saturated 













Eq. 13 and 14 show that the extent of inhibition depends on the rate constants and the ratio 𝐿 𝑙⁄ . 
Thus, in the presence of a high SBP concentration, the non-cognate substrate inhibits transport in 
model B, but not in model A. In conclusion, the different non-cognate interaction mechanisms 
have a radically different influence on the inhibition of transport, ranging from a complete 
inhibition in model C to a complete preservation of transport in model A.  
 
Discussion 
ABC importers constitute major uptake pathways of prokaryotes, and Type I and Type II 
importers require an extra-cytoplasmic SBP for function11. Various compounds have been 
identified that are bound by SBPs but that cannot be transported by the corresponding ABC 
importer6,23-28. Most of the examined non-cognate substrates induce an SBP conformation that is 
different from the conformation that is formed with cognate substrates20,34,35. Thus, transport can 
fail because the non-cognate substrate-SBP complex cannot dock onto the TMD or the docked 
SBP cannot provide the signal for transport activation (Figure 1). Other non-cognate substrates 
lock the SBP in the closed state and transport fails because the SBP cannot transfer the substrate 
to the translocator20,30. We cannot rule out that other non-cognate substrate interaction 
mechanisms exist. For instance, in certain ABC importers non-cognate substrates might directly 
affect the transport by binding to cavities within the membrane domain. In MalFGK2













55 from Thermoanaerobacter tengcongensi substrate-binding pockets have been 
identified inside the TMDs. Similar solvent-filled cavities within the TMDs have not been 
observed in the high-resolution structures of other ABC importers56-58, although pockets through 
which the substrate passes in the transition of the TMD from outward- to inward-facing must be 
present. The binding pockets within the TMDs have been linked to the regulation of transport59,60, 
however, we believe that further molecular details are required to model these interaction 
mechanisms. For instance, it is unknown how a trapped non-cognate substrate is removed from 
the binding pockets of the TMDs and how the importer resets to its resting state.   
Here, we used rate equations to model different non-cognate SBP-interaction mechanisms and 
analysed their effect on the steady-state transport rate. We conclude that when the same substrate, 
SBP and translocator concentrations and the common set of rate constants are used, a hierarchy in 
the extent of inhibition exists among the models (Figures 3). More specifically, inhibition is most 
severe when the non-cognate substrate binds irreversibly to the SBP (model C; Figure 1). 
Inhibition is less prominent, when the binding is reversible and the SBP with a non-cognate 
substrate bound can dock onto the translocator (model B; Figure 1). When the binding is 
reversible, but the SBP with a non-cognate substrate bound cannot dock (model A; Figure 1), then 
the extent of inhibition is the least of all three mechanisms. In model A only a fraction of the total 
SBP population is effectively taken out by the binding of non-cognate substrate. In model B, the 
non-cognate substrate-bound SBP can dock onto the translocator, so only a fraction of both the 
SBP and translocator population is effectively taken out by the non-cognate substrate. This 
explains why transport in model B is always slower than in model A. In model C, the non-cognate 
substrate binds irreversibly, and more SBPs have a non-cognate substrate bound than in model B. 
Therefore, the SBPs that can effectively participate in transport is reduced even further in model C 
when compared to model B.  
Analytical results were obtained in the presence of low and high substrate concentrations 
(Section ’Low substrate concentration’ and ‘High substrate concentration’, respectively). We 
observe that transport in model A, B and C is not influenced by the non-cognate substrate when 
both cognate and non-cognate substrates are present at low concentrations (Figure 4). When the 
non-cognate substrate concentration is well below the SBP and translocator concentration, then 
these protein concentrations can only be changed by an amount that is smaller than the non-
cognate substrate concentration, which in this limit is negligible when compared to the total 
protein concentrations. The conclusion holds irrespective of the rate constants. Thus, it should 
even apply when different cognate and/or non-cognate substrates are compared. For example, the 
non-cognate substrates arginine and lysine have in common that they do not trigger closing of 












arginine binding by SBD1 is more than one order of magnitude lower than that of lysine20. This 
implies that also their association (k7) and/or dissociation (k8) rate constants are different, because 
KD = k8/ k7. Since Eq. 3 is independent of these rate constants, their effect on transport is the 
same, i.e., transport of glutamine and asparagine by GlnPQ is not inhibited at low concentrations 
of arginine and lysine. These predictions can be verified experimentally, by performing uptake 
assays at substrate concentrations that are below the SBP and translocator concentration. 
Contrary to the inhibition at low substrate concentrations, the different non-cognate interaction 
mechanisms inhibit transport completely differently in the limit that the non-cognate and cognate 
substrates and SBPs are present at saturating concentrations (see Eq. 11, 12 and 13). In this limit, 
transport is completely inhibited in model C, but not in model A and B. Interestingly, transport in 
model A is unaffected by the presence of non-cognate substrate, even if the concentration is much 
higher than that of the cognate substrate. In contrast, transport is inhibited in model B, with an 
amount that depends on the rate constants and the cognate and non-cognate substrate 
concentrations. The interpretation of this result is simple. First, when the non-cognate substrate 
binds irreversibly to the SBP and the non-cognate substrate concentration is higher than the SBP 
concentration, then the SBPs are saturated with non-cognate substrate, and SBPs are no longer 
available for transport. In model A and B, the binding is reversible, so an SBP contains either a 
cognate or non-cognate substrate. In model B, the SBPs with a cognate substrate compete for 
docking onto the translocator with the SBPs that have a non-cognate substrate bound, thereby 
causing partial inhibition of transport. In model A, these SBPs do not compete, so that transport 
becomes unaffected by the presence of non-cognate substrate. These conclusions hold irrespective 
of the rate constants and should therefore even apply when different cognate and/or non-cognate 
substrates are compared.  
In conclusion, the different mechanisms of substrate inhibition have strongly varying impact 
on the transport kinetics of ABC importers, which might explain how prokaryotes maintain 
efficient uptake in chemical diverse external environments and might contribute to the 
development of effective inhibitors against SBPs of pathogenic bacteria.  
 
Methods 
The system of nonlinear equations was numerically solved with the software package MATLAB 
(MathWorks). The solution was iteratively found using the Trust Region method together with the 
Dogleg approach, as implemented in the fsolve function. Default settings of the fsolve function 
were used, except for certain thresholds of convergence. Convergence was reached when the 











smaller than 10-12 -10-14. The initial conditions were varied in case no convergence was reached. 
The source code for the numerical calculations is available at a dedicated GitHub repository 
(https://github.com/MJdeBoer/Kinetic_model). Exact solutions were found with the software 
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Figure 1. Transport model of Type I ABC importers. Reaction scheme of model 0, A, B and C. 
Rate constants are denoted above the arrows and the states Xj are depicted as cartoon. The cognate and 
non-cognate substrates are shown in green and red, respectively. The SBP is depicted in light grey and 














































































Figure 2. Transport rate in the presence and absence of non-cognate substrate. Numerical 
calculation of the steady-state transport rate in the absence of non-cognate substrate (model 0; black 
line) and in the presence of a total non-cognate substrate concentration of L = 15 µM for model A (red 
line), B (blue line) and C (yellow line) at various total cognate substrate concentrations l is shown. The 
total SBP (𝑏) and total translocator (𝑟) concentration are 20 and 1 µM, respectively.   





































Figure 3. Normalized transport rate for model A, B and C with random model parameters. A set 
of model parameters that consist of the rate constants and the total cognate substrate, non-cognate 
substrate, SBP, and translocator concentration were randomly drawn from a broad distribution. For 
each set of random model parameters the 𝑗𝐵, 𝑗𝐶 and 𝑗𝐷 values were calculated. A total of 8·10
4 
of 
random model parameters combinations were tested. The resulting histograms for the (𝑗𝐴, 𝑗𝐵), (𝑗𝐵, 𝑗𝐶) 
and (𝑗𝐴, 𝑗𝐶) pairs are presented in the figure, with the grey-scale indicating the frequency of 












































Figure 4. Transport at low substrate concentrations. Numerical calculation of the steady-state 
transport rate in the absence of non-cognate substrate (model 0; black line) and in the presence of non-
cognate substrate for model A (red line), B (blue line) and C (yellow line) at various cognate and non-
cognate substrate concentrations. The grey line denotes the analytic result of Eq. 3. In the calculation, 
the cognate (l) and non-cognate (L) substrate concentration are equal (l = L). The total SBP (𝑏) and 
total translocator (𝑟) concentrations are 4 and 1 µM, respectively. The rate constants were used as 
described in the Section ‘Model description’.  
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Figure 5. Transport at high substrate and high SBP concentrations. (a) Steady-state transport rate 
for model A (red), B (blue) and C (yellow) as function of the relative cognate substrate concentration 
𝑙 (𝑙 + 𝐿)⁄ , where L and l are the total non-cognate and cognate substrates concentrations, respectively. 
The total SBP (𝑏) and total translocator (𝑟) concentrations are 25 and 0.5 µM, respectively. The 
continuous line denotes the numerical solution with no approximations made and the points are the 
transport rate calculated with Eq. 6, 7 and 8 as indicated. The normalized steady-state transport rate as 
a function of the relative non-cognate substrate concentration 𝐿 (𝑙 + 𝐿)⁄  and various SBP 
concentrations for model A (b) and B (d) calculated with Eq. 9 and 10. Relative population of the free 
translocator state 𝑋5
𝐴 𝑟⁄  (c) and 𝑋5
𝐵 𝑟⁄  (e) as function of the relative non-cognate substrate 
concentration and various SBP concentrations. In all the calculations of this figure the total substrate (l 
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- Receptors of ABC importers can bind a large variety of substrate but not all are transported 
- Failure to transport a non-cognate substrate can be due to the receptor binding mechanism or 
the interaction of the receptor to the translocator unit of the ABC importer 
- A kinetic model describes the different mechanisms by which non-cognate substrates are 
bound but not translocated  
- Non-cognate substrates can affect the transport of cognate substrates in competitive or non-
competitive manner 
Jo
ur
na
l P
re
-p
ro
of
Journal Pre-proof
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
